[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642886":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":31,"locations":41,"responsibleParty":65,"collaborators":25,"id":68,"slug":25,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":25,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":25,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":88,"overallStatus":44,"whyStopped":25,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"State University of New York at Buffalo","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"VNS ON","EXPERIMENTAL","Receives active stimulation during therapy",[13],"Device: Vagus Nerve Stimulation Therapy",{"label":15,"type":16,"description":17,"interventionNames":18},"VNS OFF","SHAM_COMPARATOR","No stimulation during therapy",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Vagus Nerve Stimulation Therapy","Implanted vagus nerve stimulation (VNS) therapy for post-stroke recovery (Vivistim System, MicroTransponder, Austin, TX, USA)",[15,9],null,[27],{"name":28,"affiliation":29,"role":30},"Assaf Berger, MD","University at Buffalo","PRINCIPAL_INVESTIGATOR",[32,38],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},"Ellen M Carl, PhD, CCRP","CONTACT","716-218-1000","7260","ecarl@ubns.com",{"name":39,"role":34,"phone":35,"phoneExt":25,"email":40},"Amylynn M Liskiewicz, MA, CCRP","aliskiewicz@ubns.com",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"University at Buffalo Neurosurgery","RECRUITING","Buffalo","New York","14203","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-78.87837,42.88645,{"lat":54,"lon":53},[57,58,59,60,63],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},{"name":39,"role":34,"phone":35,"phoneExt":25,"email":40},{"name":28,"role":30,"phone":25,"phoneExt":25,"email":25},{"name":61,"role":62,"phone":25,"phoneExt":25,"email":25},"Jonathan Riley, MD","SUB_INVESTIGATOR",{"name":64,"role":62,"phone":25,"phoneExt":25,"email":25},"Sue Ann Sisto, MD",{"type":30,"investigatorFullName":66,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Assaf Berger","Assistant Professor of Neurosurgery","100642886",false,"NCT07643337","Impact of VNS With Rehab on Gait Post-Stroke","The Impact of Vagus Nerve Stimulation Paired With Rehabilitation on Lower Limb and Gait Functions After Ischemic Stroke","Inclusion Criteria:\n\n* Approved for Vagus Nerve Stimulation (VNS) and rehabilitation therapy\n* ≥22 years and ≤ 80 years\n* Only patients who elect to undergo VNS therapy for stroke-related upper limb deficits\n* Residual active movement in the affected limb's thumb and other 2 fingers\n* Stroke-related deficits in the lower limbs and gait with a Functional Ambulation Category (FAC) ≥3\n* Able to follow simple instructions and independently walk short distances with or without external support or leg orthoses, but without manual contact with another person\n\nExclusion Criteria:\n\n* Intact lower limb functions (Fugl-Meyer score=34)\n* Not a candidate for VNS therapy according to FDA guidelines\n* Pregnant patients","ALL","22 Years","80 Years",{"count":78,"type":79},24,"ESTIMATED","INTERVENTIONAL",[82],"NA","This is a prospective, double-blinded, randomized controlled study to evaluate the impact of Vagus Nerve Stimulation (VNS) therapy on lower limb function.",[85,86,87],"Upper Limb Deficit","Stroke Gait Rehabilitation","Stroke",[89,90,91],"vagus nerve stimulation","stroke rehabilitation","stroke related upper limb deficit","2026-06-08",{"date":94,"type":95},"2026-06-11","ACTUAL",{"date":97,"type":79},"2026-06",{"date":99,"type":79},"2028-02-23",{"name":5,"class":6},1]